284 related articles for article (PubMed ID: 25520293)
1. Imaging biomarkers in primary brain tumours.
Lopci E; Franzese C; Grimaldi M; Zucali PA; Navarria P; Simonelli M; Bello L; Scorsetti M; Chiti A
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(4):597-612. PubMed ID: 25520293
[TBL] [Abstract][Full Text] [Related]
2. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
Galldiks N; Langen KJ
Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive metabolic imaging of brain tumours in the era of precision medicine.
Kim MM; Parolia A; Dunphy MP; Venneti S
Nat Rev Clin Oncol; 2016 Dec; 13(12):725-739. PubMed ID: 27430748
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
5. PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma.
Puttick S; Bell C; Dowson N; Rose S; Fay M
Drug Discov Today; 2015 Mar; 20(3):306-17. PubMed ID: 25448762
[TBL] [Abstract][Full Text] [Related]
6. Imaging biomarkers of brain tumour margin and tumour invasion.
Price SJ; Gillard JH
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S159-67. PubMed ID: 22433826
[TBL] [Abstract][Full Text] [Related]
7. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
8. Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.
Waerzeggers Y; Ullrich RT; Monfared P; Viel T; Weckesser M; Stummer W; Schober O; Winkeler A; Jacobs AH
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S179-95. PubMed ID: 22433828
[TBL] [Abstract][Full Text] [Related]
9. Quantitative imaging biomarkers in neuro-oncology.
Waldman AD; Jackson A; Price SJ; Clark CA; Booth TC; Auer DP; Tofts PS; Collins DJ; Leach MO; Rees JH;
Nat Rev Clin Oncol; 2009 Aug; 6(8):445-54. PubMed ID: 19546864
[TBL] [Abstract][Full Text] [Related]
10. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
[TBL] [Abstract][Full Text] [Related]
11. [Neuroimaging in brain tumors].
Arbizu J; Domínguez PD; Diez-Valle R; Vigil C; García-Eulate R; Zubieta JL; Richter JA
Rev Esp Med Nucl; 2011; 30(1):47-65. PubMed ID: 21211868
[TBL] [Abstract][Full Text] [Related]
12. The pre-requisite of a second-generation glioma PET biomarker.
Borbely K; Wintermark M; Martos J; Fedorcsak I; Bognar L; Kasler M
J Neurol Sci; 2010 Nov; 298(1-2):11-6. PubMed ID: 20739034
[TBL] [Abstract][Full Text] [Related]
13. 13N-Ammonia PET/CT for detection of recurrent glioma: a prospective comparison with contrast-enhanced MRI.
Khangembam BC; Sharma P; Karunanithi S; Singhal A; Das CJ; Kumar P; Julka PK; Bandopadhyaya GP; Kumar R; Malhotra A; Bal C
Nucl Med Commun; 2013 Nov; 34(11):1046-54. PubMed ID: 24025920
[TBL] [Abstract][Full Text] [Related]
14. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
[TBL] [Abstract][Full Text] [Related]
15. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.
Munck Af Rosenschöld P; Engelholm S; Ohlhues L; Law I; Vogelius I; Engelholm SA
Acta Oncol; 2011 Aug; 50(6):777-83. PubMed ID: 21767174
[TBL] [Abstract][Full Text] [Related]
16. Advances in Magnetic Resonance Imaging and Positron Emission Tomography Imaging for Grading and Molecular Characterization of Glioma.
Chung C; Metser U; Ménard C
Semin Radiat Oncol; 2015 Jul; 25(3):164-71. PubMed ID: 26050586
[TBL] [Abstract][Full Text] [Related]
17. Multimodality assessment of brain tumors and tumor recurrence.
Heiss WD; Raab P; Lanfermann H
J Nucl Med; 2011 Oct; 52(10):1585-600. PubMed ID: 21840931
[TBL] [Abstract][Full Text] [Related]
18. Non-routine Tracers for PET Imaging of High-grade Glioma.
Frosina G
Anticancer Res; 2016 Jul; 36(7):3253-60. PubMed ID: 27354581
[TBL] [Abstract][Full Text] [Related]
19. Update on amino acid PET of brain tumours.
Langen KJ; Galldiks N
Curr Opin Neurol; 2018 Aug; 31(4):354-361. PubMed ID: 29952832
[TBL] [Abstract][Full Text] [Related]
20. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
